Dec 19, 2014
Oncology Research at the VMTH
Basic Science Research Graduate students and faculty are researching the
following areas Cancer Epidemiology as it relates to lymphoma,
skin tumors, pediatric cancer, mesothelioma, and gastrointestinal cancer
VMDB refined for MUMS classification Diagnostic Biomarkers for bladder cancer and
lymphoma Nuclear medicine and imaging of solid tumors
including lymphoma Developmental therapeutics – in vitro and in vivo
preclinical assessment of novel therapies Photoacoustic identification of tumor cells in lymph
nodes NEWS mutation assessment in Standard Poodles
Oncology Research at the VMTH
Current Clinical trials (client-owned pets): Satraplatin – new oral platinum chemotherapy agent Elsamitrucin – novel injectable chemotherapy agent with
lesser toxicity than similar drugs Intralesional yttrium and holmium - new
radiopharmaceutical technique to treat bone cancer SPI-1620- novel drug to increase blood flow (and drug
delivery) to tumors mTOR inhibitor to treat bone cancer that has
metastasized to lung Inhalant chemotherapy for primary and metastatic lung
cancer rhIL-2/IL-12 targeted therapy of melanoma Proteomic cancer screening – studies to identify
biomarkers for earlier cancer detection Comparative endoscopy- collaboration with Med School to
refine minimally-invasive tumor excision methods
Translational and Comparative Oncology
National Consortium Membership and Participation Comparative Oncology Trials Consortium –
translational research/clinical trial consortium under the NCI umbrella
Canine Comparative Oncology and Genomics Consortium – MU is one of seven institutions selected to participate in this biospecimen repository development